Curia Global, Inc.

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Mersana Ends 2022 With Third Big Pharma

H. Lundbeck A/S is the latest pharma company to benefit from the upsurge in interest in hitherto unsuccessful Alzheimer's disease assets driven by the recent controversial US approval of Biogen, Inc

Alvogen, Inc. and sister company Alvotech have announced a donation of $100,000to UNICEF to help get COVID-19 vaccines to over 90 low-and-middle-income countries. Alvogen revealed that it had signe

To “deepen commercial and manufacturing expertise and position the company to capture full potential across businesses,” US generics player, ANI Pharmaceuticals, Inc. , has hired three key executives